IMA is loading

Main Financial Data 2002

Main Data: 31/12 Year 2002
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 353.41
– gross margin 160.06
– total operating cost 107.86
– net operating profit 47.12
– financial expenses, net 4.25
– net income before taxes 24.43

 

Consolidated balance sheet Millions/Euro
– operating capital 84.95
– fixed assets, net 105.72
– reserves and MLT non financial payables – 14.25
– net financial position – 67.25
– stockholders’ equity 109.17

 

Other information Millions/Euro
– depreciation 15.00
– R & D expenses 18.38

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,344

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2002
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 136.30
– gross margin 61.35
– total operating cost 53.47
– net operating profit 5.49
– financial expenses, net 9.99
– net income before taxes 6.08

 

Consolidated balance sheet Millions/Euro
– operating capital 77.46
– fixed assets, net 110.28
– reserves and MLT non financial payables – 25.35
– net financial position – 71.38
– stockholders’ equity 91.01

 

Other information Millions/Euro
– depreciation 7.31
– R & D expenses 9.50

 

  No.
Employees 2,320

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2002
  Millions/Euro  
tea, herbs & coffee 49.78 14.09%
pharmaceuticals packaging 208.35 58.95%
pharmaceuticals processing 95.28 26.96%
Total 353.41 100.00%

 

Net Sales by Country: Year 2002
  Millions/Euro  
E.U. (excluding Italy) 139.18 39.38%
Other European countries 30.00 8.49%
North America 77.55 21.94%
Asia & Middle East 46.66 13.20%
Other countries 29.99 8.49%
Total exports 323.38 91.50%
Italy 30.03 8.50%
Total 353.41 100.00%